Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCG Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02143804
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh GradeNon Muscle Invasive
CG Oncology, Inc.
Early research (Phase 1)Study completedNCT00427830
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG

Who this might be right for
Tuberculosis
University of Oxford 16
Testing effectiveness (Phase 2)Study completedNCT04884308
What this trial is testing

Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections

Who this might be right for
Cystic FibrosisBronchiectasis AdultNon-Tuberculous Mycobacteria
Johns Hopkins University 30
Early research (Phase 1)Study completedNCT05537038
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 120
Early research (Phase 1)Study completedNCT01119521
What this trial is testing

Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 82
Large-scale testing (Phase 3)Ended earlyNCT01200992
What this trial is testing

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder NeoplasmNeoplasm Recurrence, LocalTransitional Cell, Carcinoma+2 more
Bioniche Life Sciences Inc. 84
Early research (Phase 1)Study completedNCT02709278
What this trial is testing

Aerosol BCG Challenge Trial in Healthy UK Adults

Who this might be right for
Tuberculosis
University of Oxford 46
Post-approval studies (Phase 4)Study completedNCT05168709
What this trial is testing

Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction

Who this might be right for
COVID-19Vaccine ReactionImmunization; Infection
Murdoch Childrens Research Institute 51
Early research (Phase 1)Study completedNCT04563273
What this trial is testing

Clinical Study of BCG Vaccine for Intradermal Injection

Who this might be right for
Tuberculosis
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 160
Early research (Phase 1)Study completedNCT00480454
What this trial is testing

Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines

Who this might be right for
TB
University of Oxford 214
Not applicableUnknownNCT06178666
What this trial is testing

A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi

Who this might be right for
Tuberculosis
Liverpool School of Tropical Medicine 30
Testing effectiveness (Phase 2)Study completedNCT01861730
What this trial is testing

Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants

Who this might be right for
Tuberculosis
Aeras 243
Not applicableUnknownNCT05820594
What this trial is testing

Using BCG Vaccine to Understand Tuberculosis Infection

Who this might be right for
Tuberculosis
Liverpool School of Tropical Medicine 30
Early research (Phase 1)Study completedNCT05592223
What this trial is testing

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Who this might be right for
Tuberculosis
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT01194180
What this trial is testing

A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A

Who this might be right for
Tuberculosis
University of Oxford 48
Not applicableActive Not RecruitingNCT06670755
What this trial is testing

ID93/GLA-SE Vaccination + BCG Challenge

Who this might be right for
Tuberculosis
University of Oxford 48
Not applicableStudy completedNCT03526484
What this trial is testing

The Utility of Urinalysis Prior to In-Office Procedures

Who this might be right for
Urinary Tract Infections
University of Wisconsin, Madison 664
Post-approval studies (Phase 4)WithdrawnNCT05541952
What this trial is testing

BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population

Who this might be right for
Latent Tuberculosis
Federal University of Mato Grosso
Not applicableUnknownNCT04347876
What this trial is testing

Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?

Who this might be right for
COVID-19BCG Vaccination
Assiut University 100
Testing effectiveness (Phase 2)WithdrawnNCT05539989
What this trial is testing

Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa

Who this might be right for
TuberculosisHIV Infections
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Next Page